Evil, I am upset about the BLA as well. And I am MORE upset that it appears the stability issue, which is a primary reason for the more extended delay, was something that the company should have and could have dealt with upfront as soon as they knew the combo dose was potentially switching to 700 mg.

If that is true, then it confirms many of my worst fears. Namely, that they are learning as they go, and the shareholders are the ones paying the price for that learning curve.

I am rapidly losing confidence in their ability to execute. To date, I haven't sold any of my shares, but I am trending in the direction of slowly reducing my position here.

I said late August that if nothing changed by the end of September I would. I plan to stand by that statement.